Endocrinology Flashcards

1
Q

When should you screen for T2DM?

A

Age 45, screen ever 3 yrs or earlier in high risk groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a sensitive indicator of thyroid function, it is generally recommended as a first-line test for thyroid disorders.

A

TSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

weight of pituitary gland

A

~600g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood supply of the posterior pituitary

A

The posterior pituitary is supplied by the inferior hypophyseal arteries

In contrast to the anterior pituitary, the posterior lobe is directly innervated by hypothalamic neurons (supraopticohypophyseal and tuberohypophyseal nerve tracts) via the pituitary stalk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lactotropes constitute __% of anterior pituitary cells

A

20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Peak serum PRL levels (up to 30 μg/L) occur between ____ a.m.

A

4:00 and 6:00

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What makes prolactin unique among the pituitary hormones?

A

PRL is unique among the pituitary hormones in that the predominant hypothalamic control mechanism is inhibitory, reflecting tonic dopamine-mediated suppression of PRL release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

In what instances does serum prolactin rise?

A

after exercise, meals, sexual intercourse, minor surgical procedures, general anesthesia, chest wall injury, acute myocardial infarction, and other forms of acute stress

Also increases (10 fold) during pregnancy then declines rapidly within 2 weeks of parturition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the function of prolactin?

A

PRL acts to induce and maintain lactation and to suppress both reproductive function and sexual drive.

PRL inhibits reproductive function by suppressing hypothalamic (GnRH) and pituitary gonadotropin secretion and by impairing gonadal steroidogenesis in both women and men.

In the ovary, PRL blocks folliculogenesis and inhibits granulosa cell aromatase activity, leading to hypoestrogenism and anovulation.

PRL also has a luteolytic effect, generating a
shortened, or inadequate, luteal phase of the menstrual cycle. In men, attenuated LH secretion leads to low testosterone levels and decreased spermatogenesis.

These hormonal changes decrease libido and reduce fertility in patients with hyperprolactinemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most abundant anterior pituitary hormone

A

Growth hormone

Somatotrope -50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does ghrelin affect GH?

A

Induces GHRH and GH release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Peripheral target for GH

A

IGF-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Peak levels of GH secretion occurs when?

A

GH secretion is pulsatile, with highest peak levels occurring at night, generally correlating with sleep onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In what instances does GH secretion increase?

A

Elevated GH levels occur within an hour of deep sleep onset as well as after exercise, physical stress, and trauma and during sepsis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What stimulates GH release?

A

GH is stimulated by oral ghrelin receptor agonists, intravenous l-arginine, dopamine, and apomorphine (a dopamine receptor agonist), as well as by α-adrenergic pathways.

β-Adrenergic blockade induces basal GH and enhances GHRH- and insulin-evoked GH release.

On the other hand, glucose decreases GH secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which organs express the highest amount of GH receptors?

A

The liver and cartilage express the greatest
number of GH receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Organ that is the major source of IGF-1

A

Liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the effect of IGF-1 on glucose levels

A

induces hypoglycemia and improves insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Peak time of ACTH secretion

A

ACTH secretion is pulsatile and exhibits a
characteristic circadian rhythm, peaking at about 6:00 a.m. and reaching a nadir about midnight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What peptide regulates GnRH release?

A

Brain kisspeptin, a product of the KISS1 gene, regulates hypothalamic GnRH release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

syndrome that results from defective hypothalamic (GnRH) synthesis and is associated with anosmia or hyposmia due to olfactory bulb agenesis or hypoplasia

A

Kallman syndrome

Classically, the syndrome may also be associated with color blindness, optic atrophy, nerve deafness, cleft palate, renal abnormalities, cryptorchidism, and neurologic abnormalities such as mirror movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Syndrome characterized by intellectual disability, renal abnormalities, obesity, and hexadactyly, brachydactyly, or syndactyly

A

Bardet-Biedl Syndrome

Retinal degeneration begins in early childhood, and most patients are blind by age 30.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Syndrome associated with hypogonadotropic hypogonadism, hyperphagia-obesity, chronic muscle hypotonia, mental retardation, and adult-onset diabetes mellitus

A

Prader Willi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Hormone that is more likely to be affected by cranial irradiation

A

GH

GH deficiency is most common, followed by gonadotropin, thyroid, and ACTH deficiency

The development of hypopituitarism occurs over 5–15 years and usually reflects hypothalamic damage rather than primary destruction of pituitary cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Lymphocytic hypophysitis occur most commonly in which subset of the population

A

post partum women

Most patients manifest symptoms of progressive mass effects with headache and visual disturbance.

The ESR often is elevated. Because it may be indistinguishable from a pituitary adenoma on MRI, hypophysitis should be considered in a postpartum woman with a newly diagnosed pituitary mass before an unnecessary surgical intervention is undertaken.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Syndrome that occurs during post partum and presents with acute intrapituitary hemorrhagic vascular events can cause substantial damage to the pituitary and surrounding sellar structures.

A

Sheehan’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

ACTH reserve is most reliably assessed by measuring

A

ACTH and cortisol levels during insulin-induced hypoglycemia

Administering insulin to induce hypoglycemia is contraindicated in patients with active coronary artery disease or known seizure disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Syndrome with Homozygous or heterozygous mutations of the GH receptor are associated with partial or complete GH insensitivity and growth failure

A

(Laron syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Short stature should be evaluated comprehensively if a patient’s height is > __ standard deviations below the mean for age or if the growth rate has decelerated

A

3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Sequence of hormone loss in pituitary deficiency

A

The sequential order of hormone loss is usually GH → FSH/LH → TSH → ACTH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

The most validated test to distinguish pituitary-sufficient patients from those with AGHD is

A

insulin-induced (0.05–0.1 U/kg) hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Expected response of AGHD after insulin induced hypoglycemia

A

About 90% of healthy adults exhibit GH responses >5 μg/L; AGHD is defined by a peak GH response to hypoglycemia of <3 μg/L.

Contraindicated in patients with diabetes, ischemic heart disease, cerebrovascular disease, or epilepsy and in elderly patients.

Alternative stimulatory tests include intravenous arginine (30 g), GHRH (1 μg/kg), oral ghrelin receptor agonist (0.5 mg/kg), and glucagon (1 mg).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Contraindications to GH therapy

A

Contraindications to therapy include the presence of an active neoplasm, intracranial hypertension, and uncontrolled diabetes and retinopathy

Women require higher doses than men, and elderly patients require less GH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Type of cholesterol increased by GH administration

A

HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

In ACTH deficiency, The total daily dose of hydrocortisone replacement preferably should generally not exceed ___ mg daily, divided
into two or three doses.

A

20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

most common presenting feature of adult hypopituitarism even when other pituitary hormones are also deficient.

A

Hypogonadism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Screening test for
Acromegaly?
Prolactinoma?

A

See table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Screening test for Cushing’s dse

A

See table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Screening test for Gonadotropinoma

A

See table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Screening test for TSH-producing adenoma

A

See table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Transsphenoidal resection is the desired surgical approach for pituitary tumors, except for

A

rare invasive suprasellar mass surrounding the frontal or middle fossa or the optic nerves or invading posteriorly behind the clivus, which may require transcranial approaches.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Treatment of choice for prolactinoma

A

Dopamine agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Treatment for acromegaly

A

For acromegaly, somatostatin receptor ligands
(SRLs) and a GH receptor antagonist are indicated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

______ are benign, suprasellar cystic masses that present with headaches, visual field deficits, and variable degrees of hypopituitarism. They are derived from Rathke’s pouch and arise near the pituitary stalk, commonly extending into the suprasellar cistern.

A

Craniopharyngiomas

Hypopituitarism is documented in ~90%, and diabetes insipidus occurs in ~10% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Treatment for craniopharyngioma

A

Treatment usually involves transcranial or transsphenoidal surgical resection followed by postoperative radiation of residual tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

the most common cause of pituitary hormone hypersecretion and hyposecretion syndromes in adults.

A

Pituitary adenomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Syndrome associated with Pituitary hyperplasia and adenomas (10%), Atrial myxomas, Schwannomas, Adrenal hyperplasia, Lentigines

A

Carney Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

autosomal dominant syndrome characterized primarily by a genetic predisposition to parathyroid, pancreatic islet, and pituitary adenomas

A

MEN 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

syndrome that consists of polyostotic fibrous dysplasia, pigmented skin patches, and a variety of endocrine disorders, including acromegaly, adrenal adenomas, and autonomous ovarian function

A

McCune Albright

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

most common pituitary hormone hypersecretion syndrome in both men and women

A

Hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Effect of chronic renal failure on prolactin levels

A

Elevates by decreasing clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

the hallmarks of hyperprolactinemia in women.

A

Amenorrhea, galactorrhea, and infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

When is galactorrhea suspected in patients who just gave birth?

A

the inappropriate discharge of milk-containing fluid from the breast, is considered abnormal if it persists longer than6 months after childbirth or discontinuation of breast-feeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

In patients with markedly elevated PRL levels (____ μg/L), reported results may be falsely lowered because of assay artifacts;

A

> 1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Macroadenomas are >___ in diameter and may be locally invasive and impinge on adjacent structures.

A

1 cm

Tumor size generally correlates directly with PRL concentrations; values >250 μg/L usually are associated with macroadenomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

The drug Cabergoline effectively suppresses PRL for >___days after a single oral dose and induces prolactinoma shrinkage in most patients.

A

14

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Preferred dopamine agonists in pregnant patients

A

Bromocriptine

B for buntis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

What level of prolactin should you consider surgery in microadenoma

A

> 50 ug/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

When should you repeat MRI after starting patient with macroadenoma on dopamine agonist?

A

4 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

The most significant clinical impact of GH excess occurs with respect to the ____ system

A

cardiovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Confirmatory test for acromegaly

A

The diagnosis of acromegaly is confirmed by demonstrating the failure of GH suppression to <0.4 μg/L within 1–2 h of an oral glucose load (75 g)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Initial tx for acromegaly

A

Surgical resection of GH-secreting adenomas is the initial treatment for most patients

Transsphenoidal surgical resection by an experienced surgeon is the preferred primary treatment for both microadenomas (remission
rate ~70%) and macroadenomas (<50% in remission).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Drug that antagonizes endogenous GH action by blocking peripheral GH binding to its receptor. Consequently, serum IGF-1 levels are suppressed, reducing the deleterious effects of
excess endogenous GH.

A

Pegvisomant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Next step after surgery of acromegaly

A

Serotonin receptor ligands eg. octreotide, lanreotide, pasireotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Account for 70% of patients with endogenous causes of Cushing’s syndrome.

A

Pituitary corticotrope adenomas (Cushing’s
disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

most common cause of cushingoid features

A

iatrogenic hypercortisolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Primary cause of death in Cushing’s syndrome

A

Cardiovascular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Most common clinical feature of Cushing syndrome

A

Obesity and Thick skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Screening test for Cushing syndrome

A

24hr urinary free cortisol
Alternatively, overnight 1mg dexa test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

how do you differentiate ACTH secreting tumor vs ectopic ACTH secretion

A

see table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Treatment of choice for cushing disease

A

Selective transphenoidal resection

The remission rate for this procedure
is ~80% for microadenomas but <50% for macroadenomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

What is the effect of pasireotide on sugar levels

A

Notably, hyperglycemia and new-onset diabetes develop in up to 70% of patients, likely due to suppressed pancreatic secretion of insulin and incretins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What is an oral 11β-hydroxylase inhibitor used for Cushing dse that blocks adrenal gland cortisol biosynthesis, normalizes 24-h UFC in 86% of patients.

A

Osilodrostat (2 mg twice daily titrated up to 30 mg twice daily)

Elevated adrenal hormone precursors may lead
to hypokalemia and hypertension.

QTc prolongation and possibly
increased tumor volume are also reported.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What is a drug used in Cushing syndrome that is a glucocorticoid receptor antagonist, blocks peripheral cortisol action and is approved to treat hyperglycemia in Cushing’s disease?

A

Mifepristone (300–1200 mg/d)

Because the drug does not target the pituitary tumor, both ACTH and cortisol levels remain elevated, thus obviating a reliable circulating biomarker.

Side effects are largely due to general antagonism of other steroid hormones and include hypokalemia, endometrial hyperplasia, hypoadrenalism, and hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Drug that inhibits 11β-hydroxylase activity and normalizes plasma cortisol in up to 75% of patients with Cushing syndrome

A

Metyrapone (2–4 g/d)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Adrenalectomy in the setting of residual corticotrope adenoma tissue predisposes to the development of _____ syndrome, a disorder characterized by rapid pituitary tumor enlargement and increased pigmentation secondary to high ACTH levels.

A

Nelson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

most common type of pituitary adenoma and are usually macroadenomas at the time of diagnosis

A

non functioning pituitary adenoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

If PRL levels are <100 μg/L in a patient harboring a pituitary mass, what should be considered?

A

a nonfunctioning adenoma causing pituitary stalk compression should be considered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Sources of ectopic ACTH secretion

A

Bronchial, abdominal carcinoid
Small-cell lung cancer
Thymoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

critical first step in thyroid hormone synthesis.

A

Iodide uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Mutation of the _____ gene causes Pendred syndrome, a disorder characterized by defective organification of iodine, goiter, and sensorineural deafness.

A

pendrin gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

The Recommended Dietary Allowance (RDA) is
___ μg iodine per day for pregnant women and ____ μg iodine per dayfor breastfeeding women

A

220, 290

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Urinary iodine is > ___ in iodine-sufficient populations.

A

100 μg/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Excess iodide transiently inhibits thyroid iodide organification, a phenomenon known as the ____

A

Wolff-Chaikoff effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Five factors alter thyroid function in pregnancy

A

(1) the transient increase in hCG during the first trimester, which weakly stimulates the TSH-R
(2) the estrogen-induced rise in TBG during the first trimester, which is sustained during pregnancy
(3) alterations in the immune system, leading to the onset, exacerbation, or amelioration of an underlying autoimmune thyroid disease
(4) increased thyroid hormone metabolism by the placental type III deiodinase; and
(5) increased urinary iodide excretion, which can cause impaired thyroid hormone production in areas of marginal iodine sufficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Women with a precarious iodine intake (<___) are most at risk of developing a goiter during pregnancy or giving birth to an infant with a goiter and hypothyroidism.

A

50 μg/d

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Thyroid hormone requirements are increased by up to __% during pregnancy in levothyroxine-treated hypothyroid women.

A

45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

What are the differentiating factors of t3 vs t4

A

see table

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Medications that decrease conversion of T4 to T3

A

propranolol, ipodate, iopanoic acid,
amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Expected TFT in thyroid hormone resistance

A

Increased unbound T4, T3
Normal or increased TSH

Individuals with RTH do not, in general, exhibit signs and symptoms that are typical of hypothyroidism because hormone resistance is partial and is compensated by increased levels of thyroid hormone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Large retrosternal goiters can cause venous distention over the neck and difficulty breathing,
especially when the arms are raised _____

A

(Pemberton’s sign)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What is the effect of biotin supplement on TSH levels

A

falsely low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

What is the effect of androgens and nephrotic syndrome on TBG

A

dec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Serum Tg levels are increased in all types of thyrotoxicosis except

A

thyrotoxicosis factitia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Sonographic findings that are highly suggestive of thyroid malignancy

A

Sonographic patterns that combine suspicious sonographic features are highly suggestive of malignancy (e.g., hypoechoic solid nodules with infiltrative borders and microcalcifications, >90% cancer risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Sonographic findings that are highly suggestive of benign pattern of thyroid mass

A

(isoechoic solid nodules, 5–10% cancer risk).

Some patterns suggest benignity (e.g., spongiform nodules, defined as those with multiple small internal cystic areas, or simple cysts, <3% cancer risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Starting dose for LT4 for congenital hypothyroidism

A

When the diagnosis is confirmed, T4
is instituted at a dose of 10–15 μg/kg per d,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Most common symptom and sign of hypothyroidism

A

symptom: tiredness, weakness
sign: dry coarse skin, weak peripheral pulses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Next step when TSH is high but FT4 is normal

A

Request for TPO antibodies

if symptomatic, consider LT4 tx
if symptomatic, annual ff up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Dose of LT4 for clinical hypothyroidism

A

If there is no residual thyroid function, the daily replacement dose of LT4 is usually 1.6 μg/kg body weight (typically 100–150 μg), ideally taken at least 30 min before breakfast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

when does symptoms of hypothyroidism resolve after treatment with LT4

A

Patients may not experience full relief from symptoms until 3–6 months after normal TSH levels are restored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

In patients of normal body weight who are taking ≥ ____ of LT4 per d, an elevated TSH level is often a sign of poor adherence to treatment.

A

200 μg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

What should be done if you missed 1 dose of LT4?

A

Because T4 has a long half-life (7 days), patients who miss a dose can be advised to take two doses of the skipped tablets at once

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

When should subclinical hypothyroidism be treated

A

There are no universally accepted recommendations for the management of subclinical hypothyroidism, but LT4 is recommended if the patient is a woman who wishes to conceive or is pregnant or when TSH levels are >10 mIU/L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Target TSH in pregnant women

A

Because of the known increase in thyroid hormone requirements during pregnancy in hypothyroid women, LT4 therapy should be targeted to maintain a serum TSH in the normal range but <2.5 mIU/L prior to conception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

When should be TSH be checked during pregnancy?

A

thyroid function should be evaluated immediately after pregnancy is confirmed and every 4 weeks during the first half of the pregnancy, with less frequent testing after 20 weeks’ gestation (every 6–8 weeks depending on whether LT4 dose adjustment is ongoing).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Elderly patients may require ___% LESS thyroxine than younger patients

A

20

In the elderly, especially patients with known coronary artery disease, the starting dose of LT4 is 12.5–25 μg/d with similar increments every 2–3 months until TSH is normalized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

How do you treat myxedema coma?

A

LT4 can initially be administered as a single IV bolus of 200–400 μg, which serves as a loading dose, followed by a daily oral dose of 1.6 μg/kg per d, reduced by 25% if administered IV

Because T4 → T3 conversion is impaired in myxedema coma, there is a rationale for adding liothyronine (T3 ) intravenously or via nasogastric tube to LT4 treatment, although excess liothyronine has the potential to provoke arrhythmias. An initial loading dose of 5–20 μg liothyronine should be followed by 2.5–10 μg every 8 h, with lower doses chosen for smaller or older patients and those at cardiovascular risk

Parenteral hydrocortisone (50 mg every 6 h) should be administered because there is impaired adrenal reserve in profound hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Most common cause of thyrotoxicosis

A

Graves’ disease accounts for 60–80% of thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

_____ is a minor risk factor for Graves’ disease and a major risk factor for the development of ophthalmopathy

A

Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Most common symptom and sign of hyperthyroidism

A

symptom: hyperactivity, irritability, dysphoria
sign: tachycardia, AF in elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Most common cardiovascular manifestation of Graves

A

The most common cardiovascular manifestation is sinus tachycardia, often associated with palpitations, occasionally caused by supraventricular tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Where should you auscultate for thrill/bruit of thyroid in Grave’s dse

A

There may be a thrill or bruit, best detected at the inferolateral margins of the thyroid lobes, due to the increased vascularity of the gland and the hyperdynamic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Earliest manifestation of Grave’s ophthalmopathy

A

The earliest manifestations of ophthalmopathy are usually a sensation of grittiness, eye discomfort, and excess tearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

_____ refers to a form of clubbing found in <1% of patients with Graves’ disease

A

Thyroid acropachy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What is the site involved in thyroid dermopathy?

A

Thyroid dermopathy occurs in <5% of patients with Graves’ disease , almost always in the presence of moderate or severe ophthalmopathy. Although most frequent over the anterior and lateral aspects of the lower leg (hence the term pretibial myxedema), skin changes can occur at other sites, particularly after trauma.

The typical lesion is a noninflamed, indurated plaque with a deep pink or purple color and an “orange skin” appearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

What should you suspect if TFTs revealed TSH normal or increased, high unbound T4

A

TSH-secreting pituitary adenoma or thyroid hormone resistance syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Next step when TSH is low but FT4 is normal

A

measure unbound t3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

When should you schedule ff up for subclinical hyperthyroidism

A

6-12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Clinical course of Grave’s ophthalmopathy

A

The clinical course of ophthalmopathy does not follow that of the thyroid disease, although thyroid dysfunction can worsen eye signs. Ophthalmopathy typically worsens over the initial 3–6 months, followed by a plateau phase over the next 12–18 months, and then some spontaneous improvement, particularly in the soft tissue changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

When should you follow up patients with hyperthyroidism after starting treatment

A

Thyroid function tests and clinical manifestations are reviewed 4–6 weeks after starting treatment, and the dose is titrated based on unbound T4 levels.

Most patients do not achieve euthyroidism until 6–8 weeks after treatment is initiated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

When should methimazole be stopped prior to RAI and when can it be restarted?

A

Carbimazole or methimazole must be stopped 2–3 days before radioiodine administration to achieve optimum iodine uptake and can be restarted 3–7 days after radioiodine in those at risk of complications from worsening thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

% risk of hypothyroidism after RAI

A

The risk of hypothyroidism after radioiodine depends on the dosage but is at 10–20% in the first year and 5% per year thereafter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

How long shoud you avoid close prolonged contact with children and women after RAI

A

In general, patients need to avoid close, prolonged contact with children and pregnant women for 5–7 days because of possible transmission of residual isotope and exposure to radiation emanating from the gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

What precautions should be done to avoid thyrotoxic crisis prior to thyroidectomy

A

Careful control of thyrotoxicosis with antithyroid drugs, followed by potassium iodide (SSKI; 1–2 drops orally tid for 10 days), is needed prior to surgery to avoid thyrotoxic crisis and to reduce the vascularity of the gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Birth defect associated with methimazole

A

Aplasia cutis

PTU should be used until 14-16 weeks

However, because of its rare association with hepatotoxicity, propylthiouracil should be limited to the first trimester and then maternal therapy should be converted to methimazole (or carbimazole) at a ratio of 15–20 mg of propylthiouracil to 1 mg of methimazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

How do you manage thyroid storm

A

Large doses of propylthiouracil (500–1000 mg loading dose and 250 mg every 4 h) should be given orally or by nasogastric tube or per rectum; the drug’s inhibitory action on T4 → T3 conversion makes it the antithyroid drug of choice.

If not available, methimazole can be used in doses of 20 mg every 6 h.

One hour after the first dose of propylthiouracil, stable iodide (5 drops SSKI every 6 h) is given to block thyroid hormone synthesis via the Wolff-Chaikoff effect (the delay allows the antithyroid drug to prevent the excess iodine from being incorporated into new hormone).

Propranolol should also be given to reduce tachycardia and other adrenergic manifestations (60–80 mg PO every 4 h, or 2 mg IV every 4 h).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Treatment for severe Grave’s ophthalmopathy

A

Pulse therapy with IV methylprednisolone (e.g., 500 mg of methylprednisolone once weekly for 6 weeks, then 250 mg once weekly for 6 weeks) is preferable to oral glucocorticoids, which are used for moderately active disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

In children and young adults, the most common cause of acute thyroiditis

A

presence of a piriform sinus

usually due to a bacterial infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Other name for subacute thyroiditis

A

de Quervain’s thyroiditis, granulomatous thyroiditis, or viral thyroiditis

The patient usually presents with a painful and enlarged thyroid, sometimes accompanied by fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

treatment for subacute thyroiditis

A

Relatively large doses of aspirin (e.g., 600 mg every 4–6 h) or nonsteroidal anti-inflammatory drugs (NSAIDs) are sufficient to control symptoms in many cases.

If this treatment is inadequate, or if the patient has marked local or systemic symptoms, glucocorticoids should be given. The usual starting dose is 15–40 mg of prednisone, depending on severity. The dose is gradually tapered over 6–8 weeks, in response to improvement in symptoms and the ESR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

What subset of population is silent thyroiditis associated?

A

Painless thyroiditis, or “silent” thyroiditis, occurs in patients with underlying autoimmune thyroid disease and has a clinical course similar to that of subacute thyroiditis. The condition occurs in up to 5% of women 3–6 months after pregnancy and is then termed postpartum thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

Treatment for silent thyroiditis

A

Glucocorticoid treatment is not indicated for silent thyroiditis. Severe thyrotoxic symptoms can be managed with a brief course of propranolol, 20–40 mg three or four times daily. Thyroxine replacement may be needed for the hypothyroid phase but should be withdrawn after 6–9 months, as recovery is the rule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

The most common clinically apparent cause of chronic thyroiditis is ___________ , an autoimmune disorder that often presents as a firm or hard goiter of variable size

A

Hashimoto’s thyroiditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

The most common hormone pattern in sick euthyroid syndrome (SES), also called nonthyroidal illness (NTI), is

A

a decrease in total and unbound T3 levels (low T3 syndrome) with normal levels of T4 and TSH.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

TFT abnormalities in the ff
Acute liver disease?
Acutely ill psyciatric patients?
HIV infection?
Renal disease?

A

Acute liver disease is associated with an initial rise in total (but not unbound) T3 and T4 levels due to TBG release

. A transient increase in total and unbound T4 levels, usually with a normal T3 level, is seen in 5–30% of acutely ill psychiatric patients. TSH values may be transiently low, normal, or high in these patients.

In the early stage of HIV infection, T3 and T4 levels rise, even if there is weight loss. T3 levels fall with progression to AIDS, but TSH usually remains normal.

Renal disease is often accompanied by low T3 concentrations, but with normal rather than increased rT3 levels, due to an unknown factor that increases uptake of rT3 into the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

Moreover, because amiodarone is stored in adipose tissue, high iodine levels persist for >___ months after discontinuation of the drug

A

6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Most effective long term solution for amiodarone induced thyroiditis

A

thyroidectomy

139
Q

T/F

Thyroid function tests should be performed in all patients with goiter

A

True

to exclude thyrotoxicosis or hypothyroidism

140
Q

Low urinary iodine levels (____) support a diagnosis of iodine deficiency

141
Q

What are the UTZ findings suggestive of malignant thyroid mass in terms of composition, echogenicity, shape, margin and echogenic foci

142
Q

In patients with thyroid mass, Tracheal deviation is common, but compression must usually exceed ___ % of the tracheal diameter before there is significant airway compromise

143
Q

In hyperfunctioning solitary nodule, Thyrotoxicosis is usually mild and is generally only detected when a nodule is >____

144
Q

Tx of choice for hyperfunctioning solitary nodule

145
Q

the most common malignancy of the endocrine
system

A

Thyroid carcinoma

146
Q

Risk Factors for Thyroid Carcinoma in Patients with Thyroid Nodule from History and Physical Examination

147
Q

Activation of the _____ signaling pathway is seen in up to 70% of PTCs, although the types of mutations are heterogeneous

A

RET-RAS-BRAF

148
Q

Most common type of thyroid CA

149
Q

T/F

Micrometastases is associated with poorer prognosis in PTCA

A

F

Micrometastases, defined as <2 mm of cancer in a lymph node, do not affect prognosis

However, gross metastatic involvement of multiple 2- to 3-cm lymph nodes indicates a 25–30% chance of recurrence and may increase mortality in older patients

150
Q

Therefore, near-total thyroidectomy is appropriate for tumors >___ or in the presence of metastases or clinical evidence of extrathyroidal invasion.

151
Q

Mainstay of thyroid CA tx

A

Because most tumors are still TSH-responsive, LT4 suppression of TSH is a mainstay of thyroid cancer treatment

152
Q

Target TSH for PTCA with the ff risk
Low risk?
Intermediate ?
High?
Known mets?

A

low risk = 0.5–2.0 mIU/L
Intermediate = 0.1–0.5 mIU/L
high risk of recurrence and known mets <0.1 mIU/L

153
Q

Ideal TSH level before RAI for well differentiated thyroid CA

A

> 25 mIU/L

154
Q

sensitive marker of residual/recurrent thyroid cancer after ablation of the residual postsurgical thyroid tissue

A

Serum thyroglobulin

155
Q

Prognosis of anaplastic thyroid CA

A

The prognosis is poor, and most patients die within 6 months of diagnosis

156
Q

Most common type of lymphoma of the thyroid

A

DLBCL

highly sensitive to external radiation
Surgery should be avoided (may spread dse)

157
Q

which type of MEN has more aggresive form of MTC

158
Q

Next step if FNAB showed follicular neoplasm

A

consider molecular testing

25–40% risk of malignancy

159
Q

Next step if FNAB showed Atypia or follicular lesion of undetermined significance

A

Repeat or consider molecular testing

~10–30% risk of malignancy

160
Q

In dibetes insipidus, The 24-h urine volume exceeds __mL/kg body weight, and the 24-h urine osmolarity is < ___ mosm/L

A

The 24-h urine volume exceeds 40 mL/
kg body weight, and the 24-h urine osmolarity is <280 mosm/L

161
Q

If symptoms of urinary frequency, enuresis, nocturia, and/or persistent thirst are present in the absence of glucosuria, the possibility of DI should be evaluated by

A

collecting a 24-h urine on unrestricted fluid intake

If the osmolarity is <280 mosm/L and the volume >50 mL/kg per day, the patient has DI and should be evaluated further to determine the type.

162
Q

Next step in evaluating for DI after 24 hr urine volume and osmolarity

A

Get the basal plasma AVP

163
Q

How do you differentiate primary polydipsia from pituitary DI

A

Pituitary bright spot is present in primary polydipsia since it reflects AVP stores

164
Q

When treating DI with desmoperessin, Hyponatremia rarely develops unless urine volume is reduced to < ____ per day or fluid intake is excessive due to an associated abnormality in thirst or cognition

165
Q

Treatment for hypodipsic hyponatremia

A

administering water orally if the patient is alert and cooperative or by infusing hypotonic fluids (0.45% saline or 5% dextrose and water) if the patient is not

166
Q

Most common form of SIADH

A

The most common is one in which the AVP secretion responds normally to osmotic stimulation and suppression but the threshold or set point of the system is lower than normal

167
Q

In SIADH, the excess body water should be eliminated. If the hyponatremia is mild and largely asymptomatic, restricting total water intake to ~_______ less than urine output for several days or until the syndrome remits spontaneously will usually suffice

A

30 mL/kg per day

168
Q

Alternative treatment for SIADH if water restriction does not suffice

A

Infusion of 3% saline at a rate of ~0.05 mL/kg body weight per min raises serum sodium at a rate of ~1–2 meq/L per h, not only by replacing the slight sodium deficit but also by promoting a solute diuresis, which reduces total body water.

Alternatively, a vaptan can be used to reduce body water by increasing urine output.

169
Q

Glucocorticoid excess is diagnosed by employing

A

dexamethasone suppression test.

170
Q

How do you assess glucorticoid deficiency

A

to assess glucocorticoid deficiency, ACTH stimulation of cortisol production is used

171
Q

How is ACTH stimulation done?

A

The standard ACTH stimulation test involves administration of cosyntropin (ACTH 1-24), 0.25 mg IM or IV, and collection of blood samples at 0, 30, and 60 min for cortisol.

A normal response is defined as a cortisol level >15–20 μg/dL (>400–550 nmol/L) 30–60 min after cosyntropin stimulation, with the precise cutoff dependent on the assay used

172
Q

How is insulin tolerance test done?

A

The ITT involves administration of regular insulin 0.1 U/kg IV (dose should be lower if hypopituitarism is likely) and collection of blood samples at 0, 30, 60, and 120 min for glucose, cortisol, and growth hormone (GH), if also assessing the GH axis.

Oral or IV glucose is administered after the patient has achieved symptomatic hypoglycemia (usually plasma glucose <40 mg/dL).

A normal response is defined as a cortisol >20 μg/dL and GH >5.1 μg/L, again with assay-specific cutoff variability.

173
Q

Cortisol is inactivated to cortisone by this microsomal enzyme

A

11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)

Cortisol and aldosterone bind the mineralocorticoid receptor (MR) with equal affinity; however, cortisol circulates in the bloodstream at about a 1000-fold higher concentration.

Thus, only rapid inactivation of cortisol to cortisone by 11β-HSD2 prevents MR activation by excess cortisol, thereby acting as a tissue-specific modulator of the MR pathway

174
Q

Ectopic ACTH production is predominantly caused by occult carcinoid tumors, most frequently in the ___

A

lung, but also in thymus or pancreas.

175
Q

Screening tests for Cushings syndrome

176
Q

Next step after having positive screening test for Cushing syndrome

A

Get ACTH level

177
Q

Cutoff ACTH value for distinguishing ACTH dependent from independent Cushing

178
Q

Next step after confirming ACTH INdependent Cushings

A

CT of the adrenals

179
Q

Next step after confirming ACTH dependent Cushings

180
Q

For ACTH-dependent cortisol excess, ______ is the investigation of choice

A

magnetic resonance image (MRI) of the pituitary
but it may not show an abnormality in up to 40% of cases because of small tumors below the sensitivity of detection

181
Q

Oral agents with established efficacy in Cushing’s syndrome are

A

metyrapone and ketoconazole

Metyrapone inhibits cortisol synthesis at the level of 11β-hydroxylase , whereas the antimycotic drug ketoconazole inhibits the early steps of steroidogenesis

182
Q

most common cause of mineralocorticoid excess is

A

primary aldosteronism

183
Q

The clinical hallmark of mineralocorticoid excess is

A

hypokalemic hypertension

184
Q

Diagnostic screening for mineralocorticoid excess is not currently recommended for all patients with hypertension but should be restricted to those who

A

exhibit hypertension associated with drug resistance
hypokalemia
an adrenal mass
or onset of disease before the age of 40 years

185
Q

How long should you hold MR antagonists before doing ARR?

186
Q

What is a positive ARR

A

ARR screening is positive if the ratio is >750 pmol/L per ng/mL per hour, with a concurrently high normal or increased aldosterone

187
Q

What are the confirmatory tests for mineralocorticoid excess

A

The most straightforward is the saline infusion test, which involves the IV administration of 2 L of physiologic saline over a 4-h period.

Failure of aldosterone to suppress <140 pmol/L (5 ng/dL) is indicative of autonomous mineralocorticoid excess.

Alternative tests are the oral sodium loading test (300 mmol NaCl/d for 3 days) or the fludrocortisone suppression test (0.1 mg q6h with 30 mmol NaCl q8h for 4 days);

188
Q

Next step when Primary aldosteronism is confirmed but CT of adrenals is normal and with family of early onset hypertension

A

Dexa 0.125-0.5 mg/day

189
Q

What age should adrenal vein sampling be done in px with primary aldosteronism and unilateral adrenal mass?

190
Q

Screening test for incidentaloma

191
Q

CT scan features of an incidentaloma that makes it likely malignany

A

Tumor >= 4cm and >=20 HU

192
Q

Patients with confirmed ACC and successful removal of the primary tumor should receive adjuvant treatment with ______, particularly in patients with a high risk of recurrence as determined by tumor size >8 cm, histopathologic signs of vascular invasion, capsule invasion or violation, and a Ki67 proliferation index ≥10%

A

mitotane (o,p’DDD)

Adjuvant mitotane should be continued for at least 2 years, if side effects are tolerated. Regular monitoring of plasma mitotane levels is mandatory (therapeutic range 14–20 mg/L; neurotoxic complications more frequent at >20 mg/L).

Mitotane is usually started at 500 mg tid, with stepwise increases to a maximum dose of 2000 mg tid in days (high-dose saturation) or weeks (low-dose saturation) as tolerated.

193
Q

Most common cause of adrenal insufficiency

A

Hypothalamic-pituitary origin of disease

194
Q

Most common cause of primary adrenal insufficiency

A

autoimmune adrenalitis

195
Q

Electrolyte abnormalities present in primary adrenal insufficiency

A

adrenal insufficiency and is found in 80% of patients at presentation. Hyperkalemia is present in 40% of patients at initial diagnosis.

196
Q

Confirmatory test for adrenal insufficiency

A

The diagnosis of adrenal insufficiency is established by the short cosyntropin test

The cutoff for failure is usually defined at cortisol levels of <450–500 nmol/L (16–18 μg/dL) sampled 30–60 min after ACTH stimulation;

197
Q

Next step when adrenal insufficiency is confirmed

A

Once adrenal insufficiency is confirmed, measurement of plasma ACTH is the next step

198
Q

Treatment for acute adrenal insufficiency

A

Acute adrenal insufficiency requires immediate initiation of rehydration, usually carried out by saline infusion at initial rates of 1 L/h with continuous cardiac monitoring.

Glucocorticoid replacement should be initiated by bolus injection of 100 mg hydrocortisone, followed by the administration of 200 mg hydrocortisone over 24 h, preferably by continuous infusion or alternatively by bolus IV or IM injections.

Mineralocorticoid replacement can be initiated once the daily hydrocortisone dose has been reduced to <50 mg because at higher doses hydrocortisone provides sufficient stimulation of MRs.

199
Q

At what level of hydrocortisone requirement can you start the patient with acute adrenal insufficiency with mineralocorticoid replacement?

A

Mineralocorticoid replacement can be initiated once the daily hydrocortisone dose has been reduced to <50 mg because at higher doses hydrocortisone provides sufficient stimulation of MRs.

Mineralocorticoid replacement in primary adrenal insufficiency should be initiated at a dose of 100–150 μg fludrocortisone.

200
Q

Supraphysiologic glucocorticoid treatment with doses equivalent to _____ hydrocortisone or more will affect bone metabolism, and these patients should undergo regular bone mineral density evaluation

201
Q

How is adequacy of treatment with mineralocorticoid replacement in px with acute adrenal insufficiency be measured

A

The adequacy of treatment can be evaluated by measuring blood pressure, sitting and standing, to detect a postural drop indicative of hypovolemia. In addition, serum sodium, potassium, and plasma renin should be measured regularly. Renin levels should be kept in the upper normal reference range

202
Q

Next diagnostic step when primary adrenal insufficiency is confirmed

A

Adrenal autoantibodies

203
Q

Next diagnostic step when secondary adrenal insufficiency is confirmed

A

MRI of the pituitary

204
Q

the most common syndromic cause of obesity

A

Prader-Willi syndrome (PWS)

205
Q

Cancers associated with obesity

A

The largest effects are on colorectal, kidney, and pancreatic cancer, adenocarcinoma of the esophagus, and, in women, endometrial carcinoma

206
Q

For obese patietns it is recommended to initiate treatment with a calorie deficit of _____ compared with the patient’s habitual diet

A

500–750 kcal/d

Alternatively, a diet of 1200–1500 kcal/d for women and 1500–1800 kcal/d for men (adjusted for the individual’s body weight) can be prescribed

207
Q

How is very low calorie diet defined?

A

The primary purpose of a VLCD is to promote a rapid and significant (13- to 23-kg) short-term weight loss over a 3- to 6-month period. The proprietary formulas designed for this purpose typically supply ≤800 kcal, 50–80 g of protein, and 100% of the recommended daily intake for vitamins and minerals

208
Q

When is surgery indicated in obese patients?

209
Q

MOA of Lorcaserin for weight loss

A

5-HT2C receptor agonist

210
Q

Orlistat is a synthetic hydrogenated derivative of a naturally occurring lipase inhibitor, lipostatin,
that is produced by the mold

A

Streptomyces toxytricini.

211
Q

Definition of moderate and severe obesity

A

severe obesity (BMI ≥40 kg/m2 ) or for those with moderate obesity (BMI ≥35 kg/m2 )

212
Q

the most commonly undertaken and most accepted bypass procedure for obesity

213
Q

Criteria for diagnosing DM

214
Q

How frequent should a person diagnsed with GDM be worked up for DM

A

ADA recommends that women with a history of GDM undergo lifelong screening for the development of diabetes or prediabetes at least every 3 years

215
Q

Criteria for screening for T2DM

216
Q

useful marker of insulin secretion and allows discrimination of endogenous and exogenous sources of insulin in the evaluation of hypoglycemia

217
Q

Glucose levels > ____ mmol/L or ____ mg/dK stimulate insulin synthesis

A

3.9 mmol/L (70 mg/dL)

218
Q

The major susceptibility gene for type 1 DM is located in the HLA region on chromosome ___ .

219
Q

Most prominent gene that is a variant of the _____that has been associated with both type 2 DM and IGT in several populations

A

transcription factor 7-like 2 gene

220
Q

The ADA suggests that metformin be considered in individuals with both IFG and IGT who are at very high risk for progression to diabetes (age <__ years, BMI ≥__ kg/m2, and women with a history of GDM)

A

60 yrs
BMI >=35

221
Q

When should you screen for distal symmetric polyneuropathy in patients with DM?

A

The ADA recommends annual screening for distal symmetric polyneuropathy beginning with the initial diagnosis of diabetes and annual screening for autonomic neuropathy 5 years after diagnosis of type 1 DM and at the time of diagnosis of type 2 DM. This testing is aimed at detecting loss of protective sensation (LOPS) caused by diabetic neuropathy

mnemonic: T2DM–> 2day mo na itest

222
Q

Is nephropathy considered micro or macrovascular complication of DM?

A

microvascular

223
Q

Recommended BP for px with T2DM

A

The American Diabetes Association (ADA) recommends blood pressure control <130/80 mmHg for individuals with high cardiovascular risk and <140/90 mmHg for individuals with lower cardiovascular risk.

224
Q

hallmark of proliferative diabetic retinopathy

A

The appearance of neovascularization in response to retinal hypoxemia is the hallmark of proliferative diabetic retinopathy

225
Q

When should you screen for albuminuria for px with T2DM

A

commence 5 years after the onset of type 1 DM and at the time of diagnosis of type 2 DM

basically same timeline with dx dystal symmetric neuropathy

226
Q

The ADA suggests a protein intake of _____ in individuals with diabetic kidney disease.

A

0.8 mg/kg of body weight/day

227
Q

In px with DM, Nephrology consultation should be considered when the estimated GFR is <____ or with atypical features such as hematuria, rapidly declining renal function, or proteinuria > 3 g/day.

Referral for transplant evaluation should be made when the GFR approaches _____

A

30 mL/min per 1.743 m2

20 mL/min per 1.73 m2

228
Q

Most commonly involved CN in DM neuropathy

229
Q

The most prominent GI symptoms for DM neuropathy are

A

delayed gastric emptying (gastroparesis) and altered small- and large-bowel motility (constipation or diarrhea).

230
Q

treatment for DM cystopathy

A

Diabetic cystopathy should be treated with scheduled voiding or self-catheterization.

231
Q

Class of DM drugs that cannot be used for CHF

232
Q

A possible increased risk of lower limb amputation and Fournier’sgangrene has been reported with what type of OHAS

A

SGLT-2 inhibitor therapy.

233
Q

most common pattern of dyslipidemia in DM

A

The most common pattern of dyslipidemia is hypertriglyceridemia and reduced HDL cholesterol levels.

234
Q

Statin of choice in px with renal dse

A

Atorvastatin

235
Q

Providers should consider screening for asymptomatic PAD in individuals >50 years of age who have diabetes and other risk factors using _____

A

ankle-brachial index testing

236
Q

The most common skin manifestations of DM are ____ and ___and are usually relieved by skin moisturizers.

A

xerosis and pruritus

237
Q

What constitutes the Whipples triad of hypoglycemia?

A

Whipple’s triad: (1) symptoms consistent with hypoglycemia, (2) a low plasma glucose concentration measured with a precise method, and (3) relief of symptoms after the plasma glucose level is raised.

238
Q

When hypoglycemia is prolonged beyond ~___, cortisol and growth hormone also support glucose production and restrict glucose utilization to a limited amount (both mechanisms are reduced by ~80% compared to epinephrine).

A

~4h

Thus, cortisol and growth hormone play no role in defense against acute hypoglycemia.

239
Q

What is the primary secondary and third defense against hypoglycemia

240
Q

Many other drugs have been associated with hypoglycemia. These include commonly used drugs such as ______

A

angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists, β-adrenergic receptor antagonists, quinolone antibiotics, indomethacin, quinine, and sulfonamides.

241
Q

what is the IGFII to IGF I ratio in non beta cell tumor that cause hypoglycemia

A

The tumors are usually apparent clinically, plasma ratios of IGF-II to IGF-I are high, and free IGF-II levels (and levels of pro-IGF-II [1–21]) are elevated.

242
Q

Critical diagnostic findings in insulinoma

A

Critical diagnostic findings are a plasma insulin concentration ≥3 μU/mL (≥18 pmol/L), a plasma C-peptide concentration ≥0.6 ng/ mL (≥0.2 nmol/L), and a plasma proinsulin concentration ≥5.0 pmol/L when the plasma glucose concentration is <55 mg/dL (<3.0 mmol/L) with symptoms of hypoglycemia.

A low plasma β-hydroxybutyrate concentration (≤2.7 mmol/L) and an increment in plasma glucose level of >25 mg/dL (>1.4 mmol/L) after IV administration of glucagon (1.0 mg) indicate increased insulin (or IGF) actions

243
Q

Treatment for insulinoma

A

Surgical resection of a solitary insulinoma is generally curative.

Diazoxide, which inhibits insulin secretion, or octreotide can be used to treat hypoglycemia in patients with unresectable tumors

everolimus, an mTOR inhibitor, has also been successful in combination with the above approaches

244
Q

Treatment for hypoglycemia

A

If the patient is able and willing, oral treatment with glucose tablets or glucose-containing fluids, candy, or food is appropriate. A reasonable initial dose is 15–20 g of glucose. If the patient is unable or unwilling (because of neuroglycopenia) to take carbohydrates orally, parenteral therapy is necessary. IV administration of glucose (25 g) should be followed by a glucose infusion guided by serial plasma glucose measurements. If IV therapy is not practical, SC or IM glucagon (1.0 mg in adults) can be used, particularly in patients with T1DM.

oral glucose –> IV glucose –> SC/IM glucagon

245
Q

Symptoms of diabetes usually resolve when the plasma glucose is < ______, and thus most DM treatment focuses on achieving the second and third goals.

A

<11.1 mmol/L (200 mg/dL)

246
Q

What are the treatment goals for DM?

247
Q

To avoid exercise-related hyper- or hypoglycemia, individuals with type 1 DM should (1) monitor blood glucose before, during, and after exercise
(2) delay exercise if blood glucose is ______ and ketones are present
(3) if the blood glucose is ____ , ingest carbohydrate before exercising
(4) monitor glucose during exercise and ingest carbohydrate as needed to prevent hypoglycemia
(5) decrease insulin doses (based on previous experience) before and after exercise and inject insulin into a nonexercising area
(6) learn individual glucose responses to different types of exercise.

A

(2) >14 mmol/L (250 mg/ dL)
(3) <5.0 mmol/L (90 mg/dL)

In individuals with type 2 DM, exercise-related hypoglycemia is less common but can occur in individuals taking either insulin or insulin secretagogues.

248
Q

Frequency of SMBG monitoring in px with T1DM or T2DM

249
Q

In patients achieving their glycemic goal, the ADA recommends measurement
of the HbA1c at least _____

A

twice per year.

250
Q

Longest acting insulin

251
Q

Short-acting insulin analogues should be injected just before (______) and regular insulin (____) prior to a meal. Sometimes short-acting insulin analogues are injected just after a meal (gastroparesis, unpredictable food intake

A

<10 min

30–45 min

252
Q

Highest Hba1c reduction

A

Biguanides and sulfonylureas

253
Q

OHAS associated with pancreatitis

A

GLP 1 agonists

254
Q

OHAS associated with inc risk of hyperkalemia

A

SGLT 2 inh

255
Q

OHAS associated with elevated LFT

A

a glucosidase inhibitor

256
Q

OHAS associated with Angioedema/urticarial and immune-mediated dermatologic effects

A

DPP4 inhibitor

257
Q

OHAS associated with CHF

A

Thiozolidinediones

** also contraindicated in hepatic insuffiency

258
Q

OHAS associated with Vit B12 deficiency

A

Biguanides

259
Q

OHAS that can cause weight gain

A

TZD and Insulin secretagogues

260
Q

Contraindications to alpha glucosidase inhibitor

A

These agents should not be used in individuals with inflammatory bowel disease, gastroparesis, or a serum creatinine >177 μmol/L (2 mg/dL)

261
Q

Effect of TZD on lipid profile

A

Rosiglitazone raises low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides slightly. (Lipid profile rose sa rosi-glitazone)

Pioglitazone raises HDL to a greater degree and LDL a lesser degree but lowers triglycerides

262
Q

SGLT 2 inhibitor assoc with inc risk of bladder CA

A

dapagliflozin

263
Q

Individuals who require >____ per day of long-acting insulin should be considered for combination therapy with metformin a GLP-1 receptor agonist, or a thiazolidinedione as these can reduce insulin requirements in some individuals with type 2 DM.

264
Q

The ADA clinical guidelines state that metabolic
surgery should be considered in individuals with type 2 DM and a body mass index >___ kg/m2
if hyperglycemia is inadequately controlled
despite optimal medical therapy

265
Q

How do you differentiate DKA vs HHS vs euglycemic DKA

266
Q

Formula for corrected Na

A

(1.6-mmol/L [1.6-meq] reduction in serum sodium for each 5.6-mmol/L [100-mg/dL] rise in the serum glucose)

267
Q

Why do you shift fluid to 0.45 saline in DKA

A

The change to 0.45% saline or using lactated Ringer’s helps to reduce the trend toward hyperchloremia later in the course of DKA

268
Q

When should long acting insulin be administered in tx patients with DKA?

A

Long-acting insulin, in combination with SC short-acting insulin, should be administered as soon as the patient resumes eating, because this facilitates transition to an outpatient insulin regimen and reduces length of hospital stay.

It is crucial to continue the insulin infusion or insulin SC until adequate insulin levels are achieved by administering long-acting insulin by the SC route. Even relatively brief periods of inadequate insulin administration in this transition phase may result in DKA relapse

269
Q

In euglycemic DKA associated with SGLT2 inhibitors, the pharmacologic effect may persist for____ days following discontinuation of SGLT2 inhibitor therapy as evidenced by ongoing glucosuria despite normoglycemia (glucose <180 mg/dL), during which time relapse of ketoacidosis is common if nutritional intake has not advanced (e.g., in the postoperative setting).

270
Q

Hyperglycemia usually improves at a rate of ______ per h as a result of insulin-mediated glucose disposal, reduced hepatic glucose release, and rehydration.

A

4.2–5.6 mmol/L (50–100 mg/dL)

271
Q

When the plasma glucose reaches ______ , glucose should be added to the 0.45% saline infusion to maintain the plasma glucose in the 8.3–11.1 mmol/L (150–200 mg/dL) range, and the insulin infusion should be continued at a lower rate to inhibit ketogenesis

A

11.1– 13.9 mmol/L (200–250 mg/dL)

More rapid correction of the serum glucose can precipitate the development of cerebral edema

272
Q

When may bicarbonate be given in DKA?

A

in the presence of severe acidosis (arterial pH <7.0), sodium bicarbonate (50 mmol [meq/L] in 200 mL of sterile water with 10 meq/L KCl per h) may be administered for the first 2 h until the pH is >7.0

273
Q

In DKA, If the serum phosphate is <_____, then phosphate supplement should be considered and the serum calcium monitored

A

0.32 mmol/L (1 mg/dL)

274
Q

Glycemic goals in inpx according to ADA

A

.The ADA suggests the following glycemic goals for hospitalized patients: (1) in critically or non–critically ill patients: glucose of 7.8–10.0 mmol/L or 140–180 mg/dL; (2) in selected patients: glucose of 6.1–7.8 mmol/L or 110–140 mg/dL with avoidance of hypoglycemia; (3) the target range in the perioperative period should be 80–180 mg/dL (4.4–10.0 mmol/L)

275
Q

Insulin infusion is the preferred method for managing patients with type 1 DM over a prolonged (several hours) perioperative period or when serious concurrent illness is present (______u/h of regular insulin)

A

0.5–1.0 units

276
Q

If new-onset hyperglycemia remains during chronic treatment with supraphysiologic doses of glucocorticoid (>___ mg of prednisone or equivalent), the DM may be called “steroid-induced diabetes.”

277
Q

Current recommendations advise screening for glucose intolerance between weeks ____ of pregnancy in women not known
to have diabetes

278
Q

What constitutes the harmonizing definition of metabolic syndrome?

279
Q

The most accepted and unifying hypothesis
to describe the pathophysiology of the metabolic syndrome

A

insulin resistance

280
Q

what in the lipid profile is an excellent marker of insulin resistance

A

hyperTAG

The other major lipoprotein disturbance in the metabolic syndrome is a reduction in HDL cholesterol.

281
Q

How much in % does fibrate decrease TAG

282
Q

How much in % does nicotinic acid decrease TAG

283
Q

only currently available drug with predictable
HDL cholesterol–raising properties

A

Nicotinic acid

nicotinic acid can increase HDL cholesterol by up to 30% above baseline

284
Q

Formula for corrected Calcium

A

An algorithm to correct for protein changes adjusts the total serum calcium (in mg/dL) upward by 0.8 times the deficit in serum albumin (g/dL) or by 0.5 times the deficit in serum immunoglobulin (in g/dL).

285
Q

Effect of aluminum hydroxide on Phosphate absorption

286
Q

Effect of dec ph in calcium absorption

287
Q

when should be phosphate measured?

A

basal, fatsing state due to wide variation throughout the day

288
Q

Dent’s disease is an X-linked recessive disorder caused by inactivating mutations in ____ , a chloride transporter expressed in endosomes of the proximal tubule;

A

CLCN5

features include hypercalciuria, hypophosphatemia, and recurrent kidney stones

289
Q

Respiratory failure and cardiac dysfunction, which are reversible with phosphate treatment, may occur at serum phosphate levels of ____

A

0.5–0.8 mmol/L (1.5–2.5 mg/dL).

290
Q

What is the rate of phosphate infusion in patients with hypophosphatemia?

A

See table

Hypocalcemia, if present, should be corrected before administering IV phosphate

291
Q

Hyperphosphatemia, defined in adults as a fasting serum phosphate concentration >____, usually results from impaired glomerular filtration, hypoparathyroidism, excessive delivery of phosphate into the ECF (from bone, gut, or parenteral phosphate therapy), or a combination of these factors

A

1.8 mmol/L (5.5 mg/dL)

292
Q

What is the treatment for hyperphosphatemia?

A

> Volume expansion may enhance renal phosphate clearance.
Aluminum hydroxide antacids or sevelamer may be helpful in chelating and limiting absorption of offending phosphate salts present in the intestine.
Hemodialysis is the most effective therapeutic strategy and should be considered early in the course of severe hyperphosphatemia, especially in the setting of renal failure and symptomatic hypocalcemia

293
Q

Hypomagnesemia usually signifies substantial depletion of body magnesium stores (___mmol/kg)

294
Q

What is the disadvantage of giving IV MgSO4 over MgCl2 in correcting for hypomagnesemia

A

MgSO4 may be given IV instead of MgCl2 , although the sulfate anions may bind calcium in serum and urine and aggravate hypocalcemia

295
Q

How is hypomagnesemia treated?

A

Mild, asymptomatic hypomagnesemia may be treated with oral magnesium salts (MgCl2 , MgO, Mg[OH]2 ) in divided doses totaling 20–30 mmol/d (40–60 meq/d).

More severe hypomagnesemia should be treated parenterally, preferably with IV MgCl2 , which can be administered safely as a continuous infusion of 50 mmol/d (100 meq Mg2+/d) if renal function is normal.

If GFR is reduced, the infusion rate should be lowered by 50–75%.

296
Q

How frequent should you repeat serum magnesium monitoring while correcting for hypomagnesemia

A

aSerum magnesium should be monitored at intervals of 12–24 h during therapy, which may continue for several days because of impaired renal conservation of magnesium (only 50–70% of the daily IV magnesium dose is retained) and delayed repletion of intracellular deficits, which may be as high as 1–1.5 mmol/kg (2–3 meq/kg

297
Q

The most prominent clinical manifestations of hypermagnesemia are vasodilation and neuromuscular blockade, which may appear at serum magnesium concentrations >__ mmol/L (>_ meq/L; > _ mg/dL)

A

2 mmol/L (>4 meq/L; >4.8 mg/dL)

298
Q

How is hypermagnesemia treated?

A

Vigorous IV hydration should be attempted, if appropriate. Hemodialysis is effective and may be required in patients with significant renal insufficiency.

Calcium, administered IV in doses of 100–200 mg over 1–2 h, has been reported to provide temporary improvement in signs and symptoms of hypermagnesemia

299
Q

The most specific screening test for vitamin D deficiency in otherwise healthy individuals is a ______

A

serum 25(OH)D level.

300
Q

The National Academy of Medicine has defined vitamin D sufficiency as a vitamin D level >____, although higher levels may be required to optimize intestinal calcium absorption in the elderly and those with underlying disease states, including obesity

A

50 nmol/L (>20 ng/mL)

301
Q

In patients who are vitamin D replete and are taking adequate calcium supplementation, the 24-h urinary calcium excretion should be in the range of ____ mg/24 h

A

100–250

Levels >250 mg/24 h predispose to nephrolithiasis and should lead to a reduction in vitamin D dosage and/or calciums supplementation

302
Q

Most common cause of hypercalcemia

A

hyperparathyroidism

If hypercalcemia has been manifest for >1 year, malignancy can usually be excluded as the caus

303
Q

Second most common cause of hypercalcemia

A

malignancy

304
Q

When the calcium level is >_____ calcification in kidneys, skin, vessels, lungs, heart, and stomach occurs, and renal insufficiency may develop, particularly if blood phosphate levels are normal or elevated due to impaired renal excretion.

Severe hypercalcemia, usually defined as ≥ _______can be a medical emergency; coma and cardiac arrest can occur

A

3.2 mmol/L (12.8 mg/dL)

3.7–4.5 mmol/L (14.8–18.0 mg/dL)

**factor is 4 in converting mmol to mg/dL

305
Q

The distinctive bone manifestation of hyperparathyroidism is ____

A

osteitis fibrosa cystica

306
Q

Indications for surgery in asymptomatic primary hyperparathyroidism

307
Q

What tests should be requested for monitoring primary hyperparathyroidism

A

Annually lahat except for skeletal (1-2 yrs)

308
Q

when does calcium go down after parathyroidectomy?

A

A decline in serum calcium occurs within 24 h after successful surgery;

usually, blood calcium falls to low-normal values for 3–5 days until the remaining parathyroid tissue resumes full hormone secretion

309
Q

What level of Calcium do you usually expect Chovstek’s and Trosseaus

A

Signs of hypocalcemia include symptoms such as muscle twitching, a general sense of anxiety, and positive Chvostek’s and Trousseau’s signs coupled with serum calcium consistently <2 mmol/L (8 mg/dL)

310
Q

What is the recommended rate of infusion when correcting for hypocalcemia?

A

An infusion of 0.5–2 mg/kg per hour or 30–100 mL/h of a 1-mg/mL solution usually suffices to relieve symptoms.

Usually, parenteral therapy is required for only a few days. If symptoms worsen or if parenteral calcium is needed for >2–3 days, therapy with a vitamin D analogue and/or oral calcium (2–4 g/d) should be started (see below). It is cost-effective to use calcitriol (doses of 0.5–1 μg/d) because of the rapidity of onset of effect and prompt cessation of action when stopped, in comparison to other forms of vitamin D

311
Q

What is the effect of magnesium on PTH?

A

If magnesium deficiency is present, it can complicate the postoperative course since magnesium deficiency impairs the secretion of PTH

312
Q

responsible humoral agent in most solid tumors that cause hypercalcemia

313
Q

histolgy of solid tumor associated with hypercalcemia

A

Squamous cell tumors are most frequently associated with hypercalcemia, particularly tumors of the lung, kidney, head and neck, and urogenital tract.

314
Q

___- dependent reduction in 1,25(OH)2 D thus seems to be an important stimulus for the development of secondary hyperparathyroidism

315
Q

The bone disease seen in patients with secondary hyperparathyroidism and CKD is termed ____ and affects primarily bone turnover

A

renal osteodystrophy

316
Q

How is hypocalcemia due to secondary hyperparathyroidism treated?

A

> includes reduction of excessive blood phosphate by restriction of dietary phosphate, the use of nonabsorbable phosphate binders, and careful, selective addition of calcitriol (0.25–2 μg/d) or related analogues.

> Calcium carbonate became preferred over aluminumcontaining antacids to prevent aluminum-induced bone disease. However, synthetic gels that also bind phosphate (such as sevelamer) are now widely used, with the advantage of avoiding not only aluminum retention but also excess calcium loading, which may contribute to cardiovascular calcifications.

> Intravenous calcitriol (or related analogues), administered as several pulses each week, helps control secondary hyperparathyroidism.

317
Q

Most common form of hyperparathyroidism

A

Asymptomatic

318
Q

Lab test that may help differentiate hyperpathyroidism with other causes of hypercalcemia

A

The immunoassay for PTH usually separates hyperparathyroidism from all other causes of hypercalcemia (exceptions are very rare reports of ectopic production of excess PTH by nonparathyroid tumors).

Patients with hyperparathyroidism have elevated PTH levels despite hypercalcemia, whereas patients with malignancy and the other causes of hypercalcemia (except for disorders mediated by PTH such as lithium-induced hypercalcemia) have levels of hormone below normal or undetectable

319
Q

How can 1,25(OH)2 D levels differetiate primary hyperparathyroidism from other disorders associated with hypercalcemia?

A

1,25(OH)2 D levels are elevated in many (but not all) patients with primary hyperparathyroidism. In other disorders associated with hypercalcemia, concentrations of 1,25(OH)2 D are low or, at the most, normal

Measurement of 1,25(OH)2 D is critically valuable in establishing the cause of hypercalcemia in sarcoidosis and certain lymphomas.

320
Q

What tx option for severe hypercalcemia may present with fever?

A

Pamidronate

321
Q

What tx option for severe hypercalcemia has the highest antiresorptive properties?

322
Q

What tx option for severe hypercalcemia is associated with tachyphylaxis?

A

Calcitonin

323
Q

a monoclonal antibody that binds to RANK ligand (RANKL) and prevents it from binding to
the receptor RANK on osteoclast precursors and mature osteoclasts.

324
Q

Duration of effec of calcitonin

A

Calcitonin, after 24 h of use, is no longer effective in lowering calcium

325
Q

The malignancies in which hypercalcemia responds to glucocorticoids include

A

multiple myeloma, leukemia, Hodgkin’s disease, other lymphomas, and carcinoma of the breast, at least early in the course of the diseases

325
Q

Approach to management of severe hypercalcemia

A

Severe hypercalcemia (≥3.7 mmol/L [15 mg/dL]) requires rapid correction. IV pamidronate or zoledronate or subcutaneous denosumab should be administered.

In addition, for the first 24–48 h, aggressive sodium-calcium diuresis with IV saline should be given and, following rehydration, large doses of furosemide or ethacrynic acid, but only if appropriate monitoring is available and cardiac and renal function are adequate

326
Q

Definition of osteoporosis

A

2.5 standard deviations (SDs) or more below the mean for young healthy adults of the same sex and race—also referred to as a T-score of –2.5.

Patients who present with hip or spine fractures by definition have osteoporosis and will require treatment for both the fractureitself and the underlying skeletal disorder

327
Q

How does vitamin d insufficiency cause osteoporosis?

A

Vitamin D insufficiency leads to compensatory secondary hyperparathyroidism and is an important risk factor for osteoporosis and fractures

328
Q

How does estrogen deficiency cause bone loss?

A

Estrogen deficiency causes bone loss by two distinct but interrelated mechanisms: (1) activation of new bone remodeling sites and (2) initiation or exaggeration of an imbalance between bone formation and resorption, in favor of the latter

Loss of estrogen increases production of RANKL and reduces production of osteoprotegerin, increasing osteoclast formation and recruitment

329
Q

What are the drugs associated with osteoporosis?

A

See table

Glucocorticoids are the most common cause of medication-induced osteoporosis

330
Q

What are the indications for BMD testing?

331
Q

Indications for vertebral testing

332
Q

When osteoporosis is found associated with symptoms of rash, multiple allergies, diarrhea, or flushing, mastocytosis should be considered and excluded by using ______

A

24-h urine histamine collection or serum tryptase

332
Q

Biochemical markers of bone metabolism

333
Q

Adequate calcium intake per age group

334
Q

SERM that protects the uterus and breast from effects of estrogen and makes the use of progestin unnecessary

A

Bazedoxifene

335
Q

Tamoxifen is protective against breast CA but increases the risk for this type of CA

A

uterine

unlike raloxifene

336
Q

Contraindication of alendronate

A

contraindicated in patients who have stricture or inadequate emptying of the esophagus

337
Q

Adverse events associated with bisphosphonate

A

All bisphosphonates have been associated with some musculoskeletal and joint pains of unclear etiology, which are occasionally severe. There is potential for renal toxicity, and bisphosphonates are contraindicated in those with an estimated glomerular filtration rate <30–35 mL/min. Hypocalcemia can occur.

Also associated with osteonecrosis of the jaw and atypical femoral fracture

338
Q

What treatment for osteoporosis when discontinued is associated with rebound increase in bone turnover and bone loss

A

When denosumab is discontinued, there is a rebound increase in bone turnover and an apparent acceleration of bone loss. This likely reflects the maturation of osteoclast precursors that have accumulated in marrow when the drug was administered and can become mature bone resorbing cells once the drug is withdrawn

339
Q

a humanized antibody that blocks the osteocyte production of sclerostin, resulting in an increase in bone formation and decline in bone resorption

A

romosozumab

340
Q

a cathepsin K inhibitor, inhibits the osteoclast collagenase enzyme, preventing bone resorption but not affecting osteoclast viability

A

odanacatib

341
Q

Currently ______ measured on a fasting serum sample in the morning is the preferred marker of bone resorption, and ____ or ____ the is the preferred marker for formation

A

collagen C-telopeptide

osteocalcin or propeptide of type 1 collagen (P1NP)

342
Q

All patients on long-term (>___ months) glucocorticoids should have measurement of bone mass at both the spine and the hip using DXA

A

3

If only one skeletal site can be measured, it is best to assess the spine in individuals <60 years and the hip in those >60 years.